Priorities for the Next WHO Director-General
With the World Health Organization (WHO) slated to elect a new Director-General during the 70th World Health Assembly (WHA), what is the potential impact new leadership can bring? And more importantly are those who will be impacted paying attention? As the WHO works to implement some of the reforms agreed to during the WHA in 2016, the question global health stakeholders should be asking is: What should new leadership at the WHO do for the organization? In discussing the implications of this election, panelists from the U.S. government, academia, the NGO community, and the private sector will focus on its potential impact on the current fault lines in the global health debate.
Welcome and Introduction
- Ms. Marian Wentworth, CEO and President, Management Sciences for Health
Keynote Address
Dr. Thomas Price, U.S. Secretary for Health and Human Services
Moderator
Ms. Jenifer Healy, Counsel, Dentons US LLP
Panelists
- Ms. Jan Beagle, Deputy Executive Director, Management and Governance, UNAIDS
- Dr. Mark Dybul, Executive Director, The Global Fund to Fight AIDS, Tuberculosis and Malaria
- Mr. John Flannery, President & CEO, GE Healthcare
- Dr. Ashish Jha, Director, Harvard Global Health Institute
- Ms. Loyce Pace, President & Executive Director, Global Health Council
Closing remarks
- Dr. Ronald T. Piervincenzi, CEO, U.S. Pharmacopeial Convention
